gate Garching EN
gate Garching EN

Lumatix Biotech wins ACHEMA Start-Up Award 2022

26.08.2022 - Lumatix Biotech is one out of three winners of the ACHEMA Start-Up award. The gate-startup convinced with their solution for isolating antibodies.

Lumatix Biotech: isolation of antibodies

gate-Startup Lumatix Biotech works on increasing the availability and affordability of antibodies by developing an efficient isolation method on the basis of a light-controlled affinity matrix. It is to substitute the conventional accumulation method via Protein-A-chromatography. Being one of the three winners of the ACHEMA Start-Up Award, Lumatix Biotech receives 10.000 Euros.

ACHEMA-Start-Up Award

„The thematical bandwith of the winners reflects the diversity of solutions which the process industry offers for a broad range of topics“, Andreas Förster, general manager of DECHEMA said on the occasion of the award ceremony on 24 August 2022 in Frankfurt. „Startups and their innovation force play a major role.“

In order to boost them, DECHEMA, High-Tech Gründerfonds and Business Angels Frankfurt RheinMain supported by their premium partner Clariant had announced the ACHEMA Start-Up Award for the third time. An expert jury had chosen 10 finalists out of more than 30 applications, for the first time also from abroad, who could present themselves at the ACHEMA during a separate session and in the startup area.

Dr. Nikolaus Raupp from High Tech Gründerfonds especially emphasized the meaning of disruptive innovation by startups for a faster transormation towards a sustainable cuircular economy. Enterprises which develop solutions for this counted amongst the finalists as well as digitization topics or platforms for new pharmaceutical agents.

Joachim Reinhardt from Business Angels FrankfurtRheinMain highlighted the variety and high quality of the finalists overall. He underlined the importance of contacts for young enterprises; ACHEMA offers the finalists an excellent platform for visibility and networking

The three winners distinguished themselves not only by innovative ideas obtaining a wide coverage in the chemical and pharmaceutical industry and solving present challenges, but also by solid business plans which were put to the acid test by experts in the course of the competition.

For further information on the competition: